Ironwood Pharmaceuticals Statistics
Total Valuation
IRWD has a market cap or net worth of $577.23 million. The enterprise value is $959.57 million.
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IRWD has 163.06 million shares outstanding. The number of shares has increased by 1.81% in one year.
| Current Share Class | 163.06M |
| Shares Outstanding | 163.06M |
| Shares Change (YoY) | +1.81% |
| Shares Change (QoQ) | -8.62% |
| Owned by Insiders (%) | 2.49% |
| Owned by Institutions (%) | 71.08% |
| Float | 125.58M |
Valuation Ratios
The trailing PE ratio is 23.85 and the forward PE ratio is 2.62.
| PE Ratio | 23.85 |
| Forward PE | 2.62 |
| PS Ratio | 1.95 |
| Forward PS | 1.23 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.54 |
| P/OCF Ratio | 4.54 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 7.95, with an EV/FCF ratio of 7.56.
| EV / Earnings | 39.95 |
| EV / Sales | 3.24 |
| EV / EBITDA | 7.95 |
| EV / EBIT | 8.08 |
| EV / FCF | 7.56 |
Financial Position
The company has a current ratio of 1.13
| Current Ratio | 1.13 |
| Quick Ratio | 1.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.84 |
| Debt / FCF | 4.71 |
| Interest Coverage | 3.63 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 19.85% |
| Return on Invested Capital (ROIC) | 25.93% |
| Return on Capital Employed (ROCE) | 76.78% |
| Weighted Average Cost of Capital (WACC) | 3.50% |
| Revenue Per Employee | $2.96M |
| Profits Per Employee | $240,170 |
| Employee Count | 100 |
| Asset Turnover | 0.79 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IRWD has paid $46.01 million in taxes.
| Income Tax | 46.01M |
| Effective Tax Rate | 65.70% |
Stock Price Statistics
The stock price has increased by +151.06% in the last 52 weeks. The beta is 0.17, so IRWD's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | +151.06% |
| 50-Day Moving Average | 3.99 |
| 200-Day Moving Average | 2.48 |
| Relative Strength Index (RSI) | 50.40 |
| Average Volume (20 Days) | 3,095,887 |
Short Selling Information
The latest short interest is 13.70 million, so 8.40% of the outstanding shares have been sold short.
| Short Interest | 13.70M |
| Short Previous Month | 12.92M |
| Short % of Shares Out | 8.40% |
| Short % of Float | 10.91% |
| Short Ratio (days to cover) | 4.49 |
Income Statement
In the last 12 months, IRWD had revenue of $296.15 million and earned $24.02 million in profits. Earnings per share was $0.15.
| Revenue | 296.15M |
| Gross Profit | 201.02M |
| Operating Income | 118.76M |
| Pretax Income | 70.03M |
| Net Income | 24.02M |
| EBITDA | 120.64M |
| EBIT | 118.76M |
| Earnings Per Share (EPS) | $0.15 |
Full Income StatementBalance Sheet
The company has $215.46 million in cash and $597.80 million in debt, with a net cash position of -$382.35 million or -$2.34 per share.
| Cash & Cash Equivalents | 215.46M |
| Total Debt | 597.80M |
| Net Cash | -382.35M |
| Net Cash Per Share | -$2.34 |
| Equity (Book Value) | -261.84M |
| Book Value Per Share | -1.61 |
| Working Capital | 31.96M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $127.04 million and capital expenditures -$34,000, giving a free cash flow of $127.01 million.
| Operating Cash Flow | 127.04M |
| Capital Expenditures | -34,000 |
| Depreciation & Amortization | 1.88M |
| Net Borrowing | n/a |
| Free Cash Flow | 127.01M |
| FCF Per Share | $0.78 |
Full Cash Flow StatementMargins
Gross margin is 67.88%, with operating and profit margins of 40.10% and 8.11%.
| Gross Margin | 67.88% |
| Operating Margin | 40.10% |
| Pretax Margin | 23.65% |
| Profit Margin | 8.11% |
| EBITDA Margin | 40.74% |
| EBIT Margin | 40.10% |
| FCF Margin | 42.89% |
Dividends & Yields
IRWD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.81% |
| Shareholder Yield | -1.81% |
| Earnings Yield | 4.16% |
| FCF Yield | 22.00% |
Analyst Forecast
The average price target for IRWD is $4.94, which is 39.55% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.94 |
| Price Target Difference | 39.55% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | -10.21% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRWD has an Altman Z-Score of -3.82 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.82 |
| Piotroski F-Score | 5 |
